世界の免疫組織化学（IHC）検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Immunohistochemistry (IHC) Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14032 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、免疫組織化学（IHC）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。免疫組織化学（IHC）検査の種類別市場規模（従来型直接法、新直接法、酵素ブリッジ法、PAP法）、用途別市場規模（病院、研究所、株式会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・免疫組織化学（IHC）検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：University of Texas MD Anderson Cancer Center、Memorial Sloan Kettering Cancer Center、Mayo Clinic、Johns Hopkins Hospital、Cleveland Clinic、Dana-Farber/Brigham and Women's Cancer Center、Cedars-Sinai Medical Center、Northwestern Memorial Hospital、Seattle Cancer Care Alliance/University of Washington Medical Center、University of California San Francisco Medical Center、CancerResearchUK、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：従来型直接法、新直接法、酵素ブリッジ法、PAP法 ・用途別分析2016年-2026年：病院、研究所、株式会社、その他 ・免疫組織化学（IHC）検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・免疫組織化学（IHC）検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・免疫組織化学（IHC）検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・免疫組織化学（IHC）検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・免疫組織化学（IHC）検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Immunohistochemistry (IHC) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immunohistochemistry (IHC) Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Immunohistochemistry (IHC) Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Immunohistochemistry (IHC) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Traditional Direct Method
New Direct Method
Enzyme Bridgemethod
PAP Method

Market segment by Application, can be divided into
Hospital
Research Institute
Corporation
Other

Market segment by players, this report covers
University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Johns Hopkins Hospital
Cleveland Clinic
Dana-Farber/Brigham and Women’s Cancer Center
Cedars-Sinai Medical Center
Northwestern Memorial Hospital
Seattle Cancer Care Alliance/University of Washington Medical Center
University of California San Francisco Medical Center
CancerResearchUK
Pfizer

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Immunohistochemistry (IHC) Testing
1.2 Classification of Immunohistochemistry (IHC) Testing by Type
1.2.1 Overview: Global Immunohistochemistry (IHC) Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type in 2020
1.2.3 Traditional Direct Method
1.2.4 New Direct Method
1.2.5 Enzyme Bridgemethod
1.2.6 PAP Method
1.3 Global Immunohistochemistry (IHC) Testing Market by Application
1.3.1 Overview: Global Immunohistochemistry (IHC) Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Corporation
1.3.5 Other
1.4 Global Immunohistochemistry (IHC) Testing Market Size & Forecast
1.5 Global Immunohistochemistry (IHC) Testing Market Size and Forecast by Region
1.5.1 Global Immunohistochemistry (IHC) Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Immunohistochemistry (IHC) Testing Market Size by Region, (2016-2021)
1.5.3 North America Immunohistochemistry (IHC) Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Immunohistochemistry (IHC) Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size and Prospect (2016-2026)
1.5.6 South America Immunohistochemistry (IHC) Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Immunohistochemistry (IHC) Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunohistochemistry (IHC) Testing Market Drivers
1.6.2 Immunohistochemistry (IHC) Testing Market Restraints
1.6.3 Immunohistochemistry (IHC) Testing Trends Analysis
2 Company Profiles
2.1 University of Texas MD Anderson Cancer Center
2.1.1 University of Texas MD Anderson Cancer Center Details
2.1.2 University of Texas MD Anderson Cancer Center Major Business
2.1.3 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
2.1.4 University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 University of Texas MD Anderson Cancer Center Recent Developments and Future Plans
2.2 Memorial Sloan Kettering Cancer Center
2.2.1 Memorial Sloan Kettering Cancer Center Details
2.2.2 Memorial Sloan Kettering Cancer Center Major Business
2.2.3 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
2.2.4 Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Memorial Sloan Kettering Cancer Center Recent Developments and Future Plans
2.3 Mayo Clinic
2.3.1 Mayo Clinic Details
2.3.2 Mayo Clinic Major Business
2.3.3 Mayo Clinic Immunohistochemistry (IHC) Testing Product and Solutions
2.3.4 Mayo Clinic Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mayo Clinic Recent Developments and Future Plans
2.4 Johns Hopkins Hospital
2.4.1 Johns Hopkins Hospital Details
2.4.2 Johns Hopkins Hospital Major Business
2.4.3 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product and Solutions
2.4.4 Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Johns Hopkins Hospital Recent Developments and Future Plans
2.5 Cleveland Clinic
2.5.1 Cleveland Clinic Details
2.5.2 Cleveland Clinic Major Business
2.5.3 Cleveland Clinic Immunohistochemistry (IHC) Testing Product and Solutions
2.5.4 Cleveland Clinic Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cleveland Clinic Recent Developments and Future Plans
2.6 Dana-Farber/Brigham and Women’s Cancer Center
2.6.1 Dana-Farber/Brigham and Women’s Cancer Center Details
2.6.2 Dana-Farber/Brigham and Women’s Cancer Center Major Business
2.6.3 Dana-Farber/Brigham and Women’s Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
2.6.4 Dana-Farber/Brigham and Women’s Cancer Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Dana-Farber/Brigham and Women’s Cancer Center Recent Developments and Future Plans
2.7 Cedars-Sinai Medical Center
2.7.1 Cedars-Sinai Medical Center Details
2.7.2 Cedars-Sinai Medical Center Major Business
2.7.3 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
2.7.4 Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cedars-Sinai Medical Center Recent Developments and Future Plans
2.8 Northwestern Memorial Hospital
2.8.1 Northwestern Memorial Hospital Details
2.8.2 Northwestern Memorial Hospital Major Business
2.8.3 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product and Solutions
2.8.4 Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Northwestern Memorial Hospital Recent Developments and Future Plans
2.9 Seattle Cancer Care Alliance/University of Washington Medical Center
2.9.1 Seattle Cancer Care Alliance/University of Washington Medical Center Details
2.9.2 Seattle Cancer Care Alliance/University of Washington Medical Center Major Business
2.9.3 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
2.9.4 Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Seattle Cancer Care Alliance/University of Washington Medical Center Recent Developments and Future Plans
2.10 University of California San Francisco Medical Center
2.10.1 University of California San Francisco Medical Center Details
2.10.2 University of California San Francisco Medical Center Major Business
2.10.3 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
2.10.4 University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 University of California San Francisco Medical Center Recent Developments and Future Plans
2.11 CancerResearchUK
2.11.1 CancerResearchUK Details
2.11.2 CancerResearchUK Major Business
2.11.3 CancerResearchUK Immunohistochemistry (IHC) Testing Product and Solutions
2.11.4 CancerResearchUK Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 CancerResearchUK Recent Developments and Future Plans
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Immunohistochemistry (IHC) Testing Product and Solutions
2.12.4 Pfizer Immunohistochemistry (IHC) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immunohistochemistry (IHC) Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Immunohistochemistry (IHC) Testing Players Market Share
3.2.2 Top 10 Immunohistochemistry (IHC) Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Immunohistochemistry (IHC) Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Immunohistochemistry (IHC) Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Immunohistochemistry (IHC) Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Immunohistochemistry (IHC) Testing Revenue Market Share by Application (2016-2021)
5.2 Immunohistochemistry (IHC) Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Immunohistochemistry (IHC) Testing Revenue by Type (2016-2026)
6.2 North America Immunohistochemistry (IHC) Testing Revenue by Application (2016-2026)
6.3 North America Immunohistochemistry (IHC) Testing Market Size by Country
6.3.1 North America Immunohistochemistry (IHC) Testing Revenue by Country (2016-2026)
6.3.2 United States Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Immunohistochemistry (IHC) Testing Revenue by Type (2016-2026)
7.2 Europe Immunohistochemistry (IHC) Testing Revenue by Application (2016-2026)
7.3 Europe Immunohistochemistry (IHC) Testing Market Size by Country
7.3.1 Europe Immunohistochemistry (IHC) Testing Revenue by Country (2016-2026)
7.3.2 Germany Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
7.3.3 France Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Immunohistochemistry (IHC) Testing Market Size by Region
8.3.1 Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Region (2016-2026)
8.3.2 China Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8.3.5 India Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Immunohistochemistry (IHC) Testing Revenue by Type (2016-2026)
9.2 South America Immunohistochemistry (IHC) Testing Revenue by Application (2016-2026)
9.3 South America Immunohistochemistry (IHC) Testing Market Size by Country
9.3.1 South America Immunohistochemistry (IHC) Testing Revenue by Country (2016-2026)
9.3.2 Brazil Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Immunohistochemistry (IHC) Testing Market Size by Country
10.3.1 Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Country (2016-2026)
10.3.2 Turkey Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Immunohistochemistry (IHC) Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Immunohistochemistry (IHC) Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Immunohistochemistry (IHC) Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Immunohistochemistry (IHC) Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Immunohistochemistry (IHC) Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Region (2021-2026)
Table 6. University of Texas MD Anderson Cancer Center Corporate Information, Head Office, and Major Competitors
Table 7. University of Texas MD Anderson Cancer Center Major Business
Table 8. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 9. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Memorial Sloan Kettering Cancer Center Corporate Information, Head Office, and Major Competitors
Table 11. Memorial Sloan Kettering Cancer Center Major Business
Table 12. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 13. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 15. Mayo Clinic Major Business
Table 16. Mayo Clinic Immunohistochemistry (IHC) Testing Product and Solutions
Table 17. Mayo Clinic Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Johns Hopkins Hospital Corporate Information, Head Office, and Major Competitors
Table 19. Johns Hopkins Hospital Major Business
Table 20. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product and Solutions
Table 21. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Cleveland Clinic Corporate Information, Head Office, and Major Competitors
Table 23. Cleveland Clinic Major Business
Table 24. Cleveland Clinic Immunohistochemistry (IHC) Testing Product and Solutions
Table 25. Cleveland Clinic Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Dana-Farber/Brigham and Women's Cancer Center Corporate Information, Head Office, and Major Competitors
Table 27. Dana-Farber/Brigham and Women's Cancer Center Major Business
Table 28. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 29. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cedars-Sinai Medical Center Corporate Information, Head Office, and Major Competitors
Table 31. Cedars-Sinai Medical Center Major Business
Table 32. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 33. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Northwestern Memorial Hospital Corporate Information, Head Office, and Major Competitors
Table 35. Northwestern Memorial Hospital Major Business
Table 36. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product and Solutions
Table 37. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Seattle Cancer Care Alliance/University of Washington Medical Center Corporate Information, Head Office, and Major Competitors
Table 39. Seattle Cancer Care Alliance/University of Washington Medical Center Major Business
Table 40. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 41. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. University of California San Francisco Medical Center Corporate Information, Head Office, and Major Competitors
Table 43. University of California San Francisco Medical Center Major Business
Table 44. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product and Solutions
Table 45. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. CancerResearchUK Corporate Information, Head Office, and Major Competitors
Table 47. CancerResearchUK Major Business
Table 48. CancerResearchUK Immunohistochemistry (IHC) Testing Product and Solutions
Table 49. CancerResearchUK Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Pfizer Corporate Information, Head Office, and Major Competitors
Table 51. Pfizer Major Business
Table 52. Pfizer Immunohistochemistry (IHC) Testing Product and Solutions
Table 53. Pfizer Immunohistochemistry (IHC) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Immunohistochemistry (IHC) Testing Revenue (USD Million) by Players (2019-2021)
Table 55. Global Immunohistochemistry (IHC) Testing Revenue Share by Players (2019-2021)
Table 56. Breakdown of Immunohistochemistry (IHC) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Immunohistochemistry (IHC) Testing Players Head Office, Products and Services Provided
Table 58. Immunohistochemistry (IHC) Testing Mergers & Acquisitions in the Past Five Years
Table 59. Immunohistochemistry (IHC) Testing New Entrants and Expansion Plans
Table 60. Global Immunohistochemistry (IHC) Testing Revenue (USD Million) by Type (2016-2021)
Table 61. Global Immunohistochemistry (IHC) Testing Revenue Share by Type (2016-2021)
Table 62. Global Immunohistochemistry (IHC) Testing Revenue Forecast by Type (2021-2026)
Table 63. Global Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021)
Table 64. Global Immunohistochemistry (IHC) Testing Revenue Forecast by Application (2021-2026)
Table 65. North America Immunohistochemistry (IHC) Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Immunohistochemistry (IHC) Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Immunohistochemistry (IHC) Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Immunohistochemistry (IHC) Testing Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Immunohistochemistry (IHC) Testing Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Immunohistochemistry (IHC) Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Immunohistochemistry (IHC) Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Immunohistochemistry (IHC) Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Immunohistochemistry (IHC) Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Immunohistochemistry (IHC) Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Immunohistochemistry (IHC) Testing Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Immunohistochemistry (IHC) Testing Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Immunohistochemistry (IHC) Testing Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Immunohistochemistry (IHC) Testing Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Immunohistochemistry (IHC) Testing Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Immunohistochemistry (IHC) Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Immunohistochemistry (IHC) Testing Picture
Figure 2. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Type in 2020
Figure 3. Traditional Direct Method
Figure 4. New Direct Method
Figure 5. Enzyme Bridgemethod
Figure 6. PAP Method
Figure 7. Immunohistochemistry (IHC) Testing Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Research Institute Picture
Figure 10. Corporation Picture
Figure 11. Other Picture
Figure 12. Global Immunohistochemistry (IHC) Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Immunohistochemistry (IHC) Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Region (2016-2026)
Figure 15. Global Immunohistochemistry (IHC) Testing Revenue Market Share by Region in 2020
Figure 16. North America Immunohistochemistry (IHC) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Immunohistochemistry (IHC) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Immunohistochemistry (IHC) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Immunohistochemistry (IHC) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Immunohistochemistry (IHC) Testing Market Drivers
Figure 22. Immunohistochemistry (IHC) Testing Market Restraints
Figure 23. Immunohistochemistry (IHC) Testing Market Trends
Figure 24. University of Texas MD Anderson Cancer Center Recent Developments and Future Plans
Figure 25. Memorial Sloan Kettering Cancer Center Recent Developments and Future Plans
Figure 26. Mayo Clinic Recent Developments and Future Plans
Figure 27. Johns Hopkins Hospital Recent Developments and Future Plans
Figure 28. Cleveland Clinic Recent Developments and Future Plans
Figure 29. Dana-Farber/Brigham and Women's Cancer Center Recent Developments and Future Plans
Figure 30. Cedars-Sinai Medical Center Recent Developments and Future Plans
Figure 31. Northwestern Memorial Hospital Recent Developments and Future Plans
Figure 32. Seattle Cancer Care Alliance/University of Washington Medical Center Recent Developments and Future Plans
Figure 33. University of California San Francisco Medical Center Recent Developments and Future Plans
Figure 34. CancerResearchUK Recent Developments and Future Plans
Figure 35. Pfizer Recent Developments and Future Plans
Figure 36. Global Immunohistochemistry (IHC) Testing Revenue Share by Players in 2020
Figure 37. Immunohistochemistry (IHC) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Immunohistochemistry (IHC) Testing Revenue Market Share in 2020
Figure 39. Global Top 10 Players Immunohistochemistry (IHC) Testing Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Immunohistochemistry (IHC) Testing Revenue Share by Type in 2020
Figure 42. Global Immunohistochemistry (IHC) Testing Market Share Forecast by Type (2021-2026)
Figure 43. Global Immunohistochemistry (IHC) Testing Revenue Share by Application in 2020
Figure 44. Global Immunohistochemistry (IHC) Testing Market Share Forecast by Application (2021-2026)
Figure 45. North America Immunohistochemistry (IHC) Testing Sales Market Share by Type (2016-2026)
Figure 46. North America Immunohistochemistry (IHC) Testing Sales Market Share by Application (2016-2026)
Figure 47. North America Immunohistochemistry (IHC) Testing Revenue Market Share by Country (2016-2026)
Figure 48. United States Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Immunohistochemistry (IHC) Testing Sales Market Share by Type (2016-2026)
Figure 52. Europe Immunohistochemistry (IHC) Testing Sales Market Share by Application (2016-2026)
Figure 53. Europe Immunohistochemistry (IHC) Testing Revenue Market Share by Country (2016-2026)
Figure 54. Germany Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Immunohistochemistry (IHC) Testing Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Immunohistochemistry (IHC) Testing Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Immunohistochemistry (IHC) Testing Revenue Market Share by Region (2016-2026)
Figure 62. China Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Immunohistochemistry (IHC) Testing Sales Market Share by Type (2016-2026)
Figure 69. South America Immunohistochemistry (IHC) Testing Sales Market Share by Application (2016-2026)
Figure 70. South America Immunohistochemistry (IHC) Testing Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Immunohistochemistry (IHC) Testing Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Immunohistochemistry (IHC) Testing Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Immunohistochemistry (IHC) Testing Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Immunohistochemistry (IHC) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source

---